Trials / Completed
CompletedNCT03000413
Ketamine Efficacy for Acute Severe Bronchospasm in ICU: MACANUDO Trial
Ketamine Efficacy for Acute Severe Bronchospasm in Mechanically Ventilated-critically Ill Patients: a Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Hospital Nossa Senhora da Conceicao · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Despite few scientific evidence that could support the use of ketamine in adult patients undergoing acute bronchospasm requiring mechanical ventilation (MV), ketamine is largely employed in this setting. The aim of this study is therefore assess more definitively the real benefit of using ketamine in patients with severe bronchospasm, requiring ICU stay and need for MV in order to establish or refute the use of this drug as "standard therapy" in these cases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketamine | Active treatment |
| DRUG | Fentanyl |
Timeline
- Start date
- 2015-06-04
- Primary completion
- 2017-06-16
- Completion
- 2018-01-29
- First posted
- 2016-12-22
- Last updated
- 2024-05-21
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03000413. Inclusion in this directory is not an endorsement.